Are you patient-centric?
It’s no secret that today’s market conditions have made pharmaceutical marketing and sales much more complex and challenging. IMS projects that global pharmaceutical market growth will slow to 5% to 6% in 2008, with a compound annual rate of U.S. growth expected to range between 3% and 6% through 2012. Current industry developments – heightened safety concerns, fewer product launches, unprecedented patent expiries, and the increasing need to demonstrate product value and outcomes – are placing heavy demands on pharmaceutical companies.
Click here for the full pdf article.